Search is Powered by Google
Follow us on:
Follow our health news on Twitter
Follow Our News on Facebook
Personalization
login | register
Multiple Sclerosis News

New European Multiple Sclerosis Platform Project: Roundtable For National Endorsement Of The EMSP "Code" And Consensus Papers

Main Category: Multiple Sclerosis
Article Date: 18 Apr 2008 - 13:00 PDT

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article
Current Article Ratings:

Patient / Public:4 and a half stars

4.5 (2 votes)

Health Professional:not yet rated

Article Opinions: 0 posts

Since 2003 - year of the EP resolution - EMSP (European Multiple Scleroris Platform) has been pursuing an important advocacy work focused on health inequalities in the European Union and beyond.

The launch of the "Code of Good Practice" in 2007 has been a major milestone in the bid to raise awareness of Multiple Sclerosis and its impact on people's lives. Nevertheless MS remains under-diagnosed and sub-optimally treated in many European countries. For building up further this awareness on national level, EMSP - together with ZMSS, its Slovenian member - is organising a high-level roundtable for discussion in Slovenia on May 7th.

Expected participants are representatives of the European Commission (DG Sanco, DG Enterprise, DG Employment), the European Parliament, the Slovenian Health Ministry, the agency for medicines and products and medical devices of Slovenia, as well as medical healthcare professionals, both from European and Slovenian bodies. As it takes place during the EU Presidency of Slovenia we expect highest interest of the media for our ultimate goal to obtain endorsement and concrete actions in relation to the "Code" and its Consensus Papers.

EMSP goals are running parallel to those of the Commission's New Health strategy which includes the access to good quality care and the reduction of inequalities in health.

European Multiple Scleroris Platform (emsp)

EMSP's mission is..

-- to exchange and disseminate information relating to multiple sclerosis considering all issues relevant to people affected by MS;
-- to encourage research of all kinds that is appropriate to multiple sclerosis through recognised medical and other organisations;
-- to promote the development of join action programmes with the participation of national MS societies in Europe, aimed at improving the quality of their activities and services;
-- to act as focal point for liaison with the institutions of the European Union (EU), the Council of Europe and other European organisations, in order to study and propose measures to improve the autonomy of handicapped persons and promote their full participation in society.

www.ms-in-europe.com




Personalized Homepage Weekly Newsletters Daily News Alerts
Hemophilia Opioid Induced Constipation Pneumococcal Disease ADHD Anxiety Asthma Atrial Fibrillation Autism Cancer Diabetes Lung Cancer Lupus Medicare / Medicaid Obesity and BMI Pancreatic Cancer Stem Cells All 'What Is...' Articles

Ophthalmology Urology
About Us News Licensing Free Website Feeds Free Tools & Content Tell a Friend Accessibility Help / FAQ Article Submission Links Contact Us

add medical news today to your facebook
medical news gadget

Please fill in our survey

Swine Flu Image

Swine Flu Updates

- Latest Swine Flu News
- What is Swine Flu?
- Map Of H1N1 Outbreaks
- Swine Flu - Top 20 FAQ
- Daily Email News Alerts
Stick with Medical News Today for the latest news updates on swine flu.


These are the most read articles from this news category for the last 6 months:
Top Article Star
Hydrangea Root Shows Promise In Treating Autoimmune Disorders
05 Jun 2009
US researchers found that a drug made from the root of the hydrangea plant, which has for centuries been used in Chinese medicine, showed promising results in treating autoimmune disorders such as rheumatoid arthritis...


Talking with Your Doctor image Talking with Your Doctor

Talking with your doctor can sometimes be difficult. Good health care, however, depends on an open dialogue between patients and doctors...

An MS Drug Back on the Market image An MS Drug Back on the Market

After being suspended from the market for safety reasons, natalizumab is again available for the treatment of multiple sclerosis. Safeguards are in place because of a small risk in developing a serious brain infection. Should you consider taking this drug...

View more videos...